Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities
Net income (loss)	$ 24,425,000	$ (17,224,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	6,644,000	4,494,000
Stock-based compensation	43,074,000	31,012,000
Change in fair value of liabilities	0	468,000
Net accretion on securities	(2,281,000)	(2,517,000)
Impairment of long-lived assets	114,000	429,000
Non-cash operating lease cost	1,221,000	914,000
Non-cash acquisition-related costs	0	1,066,000
Non-cash other	412,000	55,000
Changes in operating assets and liabilities:
Inventory	(18,124,000)	145,000
Prepaid expenses and other current assets	(1,430,000)	(4,756,000)
Other long-term assets	(47,000)	(32,000)
Accounts payable	16,156,000	5,438,000
Accrued liabilities	(24,000)	7,159,000
Deferred revenue	13,257,000	586,000
Operating lease liabilities	(1,140,000)	(928,000)
Earn-out payable	(2,825,000)	0
Net cash provided by operating activities	79,432,000	26,309,000
Investing activities
Purchases of investments	(97,539,000)	(65,376,000)
Maturities of investments	126,095,000	72,334,000
Proceeds from sales of investments	0	676,000
Investment in website development and internal-use software	(6,191,000)	(4,062,000)
Purchases of property, equipment, and intangible assets	(13,793,000)	(5,312,000)
Net cash provided by (used in) investing activities	8,572,000	(1,740,000)
Financing activities
Proceeds from exercise of vested stock options	16,472,000	560,000
Payments for taxes related to net share settlement of equity awards	(22,281,000)	(7,411,000)
Repurchases of common stock	(47,996,000)	0
Proceeds from employee stock purchase plan	1,622,000	898,000
Payments for acquisition-related earn-out consideration	(3,190,000)	0
Net cash used in financing activities	(55,373,000)	(5,953,000)
Foreign currency effect on cash and cash equivalents	1,000	29,000
Increase in cash, cash equivalents, and restricted cash	32,632,000	18,645,000
Cash, cash equivalents, and restricted cash at beginning of period	97,519,000	47,628,000
Cash, cash equivalents, and restricted cash at end of period	130,151,000	66,273,000
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	129,295,000	65,417,000
Restricted cash	856,000	856,000
Total cash, cash equivalents, and restricted cash	130,151,000	66,273,000
Supplemental disclosures of cash flow information
Cash paid for taxes	3,468,000	626,000
Non-cash investing and financing activities
Purchases of property and equipment included in accounts payable and accrued liabilities	1,256,000	466,000
Right-of-use asset obtained in exchange for lease liability	2,174,000	591,000
Issuance of common stock for acquisition-related earn-out consideration	$ 1,396,000	$ 0